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Abstract
Q344ter is a naturally occurring rhodopsin mutation in humans that causes autosomal dominant retinal degeneration
through mechanisms that are not fully understood, but are thought to involve an early termination that removed the
trafficking signal, QVAPA, leading to its mislocalization in the rod photoreceptor cell. To better understand the disease
mechanism(s), transgenic mice that express Q344ter were generated and crossed with rhodopsin knockout mice. Dark-
reared Q344ter
rho+/2 mice exhibited retinal degeneration, demonstrating that rhodopsin mislocalization caused
photoreceptor cell death. This degeneration is exacerbated by light-exposure and is correlated with the activation of
transducin as well as other G-protein signaling pathways. We observed numerous sub-micrometer sized vesicles in the inter-
photoreceptor space of Q344ter
rho+/2 and Q344ter
rho2/2 retinas, similar to that seen in another rhodopsin mutant, P347S.
Whereas light microscopy failed to reveal outer segment structures in Q344ter
rho2/2 rods, shortened and disorganized rod
outer segment structures were visible using electron microscopy. Thus, some Q344ter molecules trafficked to the outer
segment and formed disc structures, albeit inefficiently, in the absence of full length wildtype rhodopsin. These findings
helped to establish the in vivo role of the QVAPA domain as well as the pathways leading to Q344ter-induced retinal
degeneration.
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Introduction
Retinitis pigmentosa (RP) comprises a group of inherited retinal
disorders characterized by initial night blindness and a progressive
loss of peripheral vision which eventually compromises visual
acuity and culminates into total blindness. Epidemiological studies
have revealed that RP is heterogeneous both genetically and
clinically, and afflicts around 1 in every 3500 to 5000 persons
worldwide [1,2]. The majority of genetic defects causing RP are
rod photoreceptor-specific, affecting proteins that include compo-
nents in the rod phototransduction cascade, structural integrity of
rod outer segment (ROS) and vectorial intracellular trafficking.
Although in most cases RP is initiated by the death of rod
photoreceptors, its progression eventually affects cones, leading to
total vision loss. Over 100 different mutations in the rhodopsin (or
rod opsin) gene alone have been linked to RP. Moreover, nearly all
RP-related rhodopsin mutations are autosomal dominant and
collectively have accounted for approximately 30% of all ADRP
cases [2,3,4,5]. Based on observations when expressed in cultured
mammalian cells [293S cells - 6,COS-1 cells - 7], ADRP-related
rhodopsin mutations were classified into two main categories:
Class I (15%) and Class II (85%). Interestingly, Class I mutants
have no obvious defective biochemical traits, for they closely
resembled wild-type (WT) rhodopsin in terms of expression levels,
regeneration by binding to 11-cis retinal, and localization to the
plasma membrane. On the other hand, Class II mutants have
characteristics distinct from WT rhodopsin: their expression levels
were markedly lowered; they failed to or poorly regenerated with
11-cis retinal; and in varying degrees they were retained in the
endoplasmic reticulum (ER). These empirical properties were
attributed to protein mis-folding [6,7,8,9].
The lack of significant biochemical abnormalities in Class I
mutants when expressed in cultured mammalian cells indicates
that these rhodopsin mutants are properly folded and capable of
forming a light-absorbing pigment [6,7,8,9]. Further investigations
have revealed that the majority of Class I mutants are clustered at
the rhodopsin carboxyl-terminus (C-terminus). Q344ter is such a
rhodopsin mutation that causes a severe form of ADRP. In the
Q344ter rhodopsin mutant, codon 344, which normally encodes
for glutamine, is converted into an early stop codon, thereby
resulting in the absence of the QVAPA domain. These five amino
acids have been shown to be the minimal sorting signal for the
proper budding and trafficking of rhodopsin-bearing transport
carriers (RTCs) in a retinal cell-free assay [10,11]. The role of the
QVAPA domain in polarized transport of rhodopsin was also
investigated in a previous study using transgenic mice that
expressed Q344ter [12]. Expressed Q344ter gave rise to largely
normal light responses, indicating that they are properly folded
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degeneration that correlated with the level of transgene expression.
In addition, rhodopsin molecules were not only observed in the
ROS but also mislocalized in the rod inner segment and outer
nuclear layer. This study showed the importance of the QVAPA
domain in the polarized transport of rhodopsin in vivo. However,
whether cell death was caused directly by rhodopsin mis-
trafficking was still not entirely clear, inasmuch as Q344ter was
expressed along with endogenous rhodopsin, and it was noted that
over-expression of rhodopsin alone can cause retinal degeneration
[12,13,14]. It was also not clear whether Q344ter alone can
transport to the outer segment in the absence of endogenous
rhodopsin; a previous morphological study of retinas from
S334ter
rho2/2 mice using light microscopy showed an absence
of outer segment structures [15]. Another variable is that the
Q344ter mice were not dark-reared. Consequently, the role of
rhodopsin mis-trafficking and the added effect of light-exposure
was not independently assessed. We addressed these questions by
1) breeding the Q344ter-expressing mice into the endogenous
rhodopsin (rho)+/2 and rho2/2 backgrounds and 2) assessing
the extent of retinal degeneration in dark-reared Q344ter mice
and comparing this to the effect of controlled light-exposure to
retinal degeneration. Consistent with a previous report, we
observed that Q344ter
rho+/2 retinas formed outer segments and
exhibited rhodopsin mislocalization to the inner segment and
outer nuclear layer compartments [12]. Outer segment structures
were not evident in the Q344ter
rho2/2 retinas by light microscopy
or immunohistochemistry on frozen sections. Electron microscopy




EM revealed outer segment structures with stacked discs in the
Q344ter
rho2/2 retinas. In addition, we provided biochemical
evidence for the light-activation of mislocalized Q344ter through
light-induced rhodopsin phosphorylation and G-protein activa-
tion. Revealing this capability of mislocalized yet properly folded
rhodopsin molecules may provide an insight towards discovering a
potential cell signaling cascade that triggers rod cell death.
Results
Generation of transgenic Q344ter rhodopsin mutant
(Q344ter) mice and quantification of transgene
expression by RT-PCR and Western blot
The Q344ter transgene construct was created by introducing a
stop codon into an 11 kb mouse genomic fragment comprising the
whole coding sequence of rod opsin and its upstream regulatory
regions [16] (Fig. 1A). Therefore, the last five amino acids,
QVAPA, are absent from this rhodopsin mutant, while the six Ser
and Thr sites that are the substrates of rhodopsin kinase (RK) [17]
are retained.
Q344ter transgenic mice were generated and mated with
rhodopsin knockout (rho2/2) mice [18] to produce Q344ter




The rho+/2 background was used to minimize retinal degener-
ation that may be induced by rhodopsin over-expression
[12,13,14]. To isolate the effect of rhodopsin mis-trafficking,
Q344ter mice and littermate controls were dark-reared except
when noted.
The level of Q344ter transgene expression was quantified by
RT- PCR. Total RNA was isolated from the retinas of dark-reared
transgenic Q344ter mice and their negative littermate controls in
rho+/2 and rho2/2 backgrounds at p28-p30. Transcripts were
reverse-transcribed into cDNA followed by PCR (RT-PCR) using
a pair of primers mapping to exon 4 and 5 to amplify a 250 bp
fragment common to both WT and Q344ter rod opsin transcripts
(Fig. 1B). The Q344ter PCR product can be distinguished from
the WT by AvrII digestion, which cuts specifically the amplified
Q344ter transgene product into 122 bp and 128 bp fragments.
Because the PCR primers amplify both WT and Q344ter with
equal efficiency, the relative proportion of Q344ter transcript in
the total the fraction can be quantitatively obtained. To determine
transgene expression levels, we compared intensities between the
AvrII-resistant fragment and the same-sized fragment in the mock-
digested fraction. As expected, almost the entire amplified PCR
product from the Q344ter
rho2/2 retinas was cleaved by AvrII,
while a proportion of the total PCR product from Q344ter
rho+/2
samples was cleaved by AvrII, and none was cleaved in the
transgene-negative samples (Fig. 1C). From the reduction of
intensity of the AvrII digested sample as compared to the total
undigested sample, we deduced that the level of transgenic gene
expression in Q344ter
rho+/2 retinas to be 24% of total rod opsin
transcripts. While a reduction in rhodopsin expression in the
rho+/2 mice appears to be well tolerated [18] (Fig. 2, A&C),
rhodopsin over-expression causes photoreceptor cell death in
transgenic mice in a dose dependent manner [12,13,14].
Inasmuch as the rhodopsin level in the Q344ter
rho+/2 retinas lies
between that of rho+/+ mice and rho+/2 mice, it is not expected
to be a contributing factor to retinal degeneration in the
Q344ter
rho+/2 retinas.
At the protein level, it is difficult to distinguish between WT
rhodopsin and Q344ter by their size difference. We therefore
relied on two mouse monoclonal anti-rhodopsin antibodies: R2-
12N and 1D4 to infer expression of Q344ter. R2-12N recognizes
rhodopsin’s N-terminal region [residues 2–12] [19], and therefore
binds to both WT rhodopsin and Q344ter; whereas 1D4
recognizes rhodopsin’s C-terminal region [residues 340–348]
[20], and therefore binds to endogenous rhodopsin but not to
Q344ter. Accordingly, Q344ter is detected by R2-12N but not
1D4 when expressed alone (Fig. 1D, rhodopsin monomer and
dimer migrate at 33 kD and 66 kD, respectively). In retinal
homogenates from Q344ter
rho+/2 and transgene-negative litter-
mate controls, rhodopsin was detected by both R2-12N and 1D4
antibodies (Fig. 1D). Here, rhodopsin content appeared to be
lower in Q344ter
rho+/2 retinas than rho+/2 retinas despite
loading equal amounts of retinal homogenates, suggesting the
occurrence of degeneration in these transgenic Q344ter retinas
(see below).
Defective rhodopsin trafficking in the Q344ter transgenic
mice causes photoreceptor cell death
To isolate the effect of rhodopsin mis-trafficking on retinal
degeneration, Q344ter
rho+/2 mice and their transgene-negative
littermate controls were born and reared in the dark. Retinal
morphology of these mice was examined at postnatal day 30 (p30)
and p60 (Fig. 2). At p30 the transgene-negative rho+/2
littermates exhibit normal retinal architecture with 10–12 layers
of photoreceptor cell nuclei, organized outer segments and
regularly stacked discs (Fig. 2A). This morphology was maintained
at p60 (data not shown). In contrast, the outer nuclear layer
thickness was reduced and the outer segments were shortened in
Q344ter
rho+/2 retinas at p30 (Fig. 2B). By p60 the outer segments
have disappeared and the outer nuclear layer had thinned to 2–3
cell layers (Fig. 2C). At the ultrastructural level the outer segments
of transgene-negative rho+/2 mice at p30 showed organized
stacks of disc membranes (Fig. 2D). These structures appeared less
organized in the Q344ter
rho+/2 mice (Fig. 2E). In addition,
numerous small vesicles that range from 100 to 200 nm in
Q344ter-Induced Cell Death
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eceptor space (Fig. 2E, asterisks). The origin of these vesicles is
unknown, although their proximity and similarity in electron
density suggest that they may be formed from degenerating
cellular structures (Fig. 2E, arrow). No vesicles were observed in
the outer nuclear layer compartment proximal to the outer
limiting membrane (Fig. 2F). The vesicles are reminiscent of that
observed by Li et al. in retinas of transgenic mice that express the
rhodopsin mutant P347S [21].
Rhodopsin localization was assessed on frozen retinal sections
(Fig. 3). Rhodopsin immunoreactivity is normally localized
predominantly in the outer segment, as can be seen in the
transgene-negative rho+/2 controls (Fig. 3, B&D). However,
rhodopsin reactivity extended to the outer nuclear layer (ONL)
and inner segment when Q344ter was expressed (Fig. 3A).
Q344ter
rho+/2 retinal sections were also reacted with 1D4, the
epitope of which has been mapped to the last nine residues at the
carboxyl-terminus of rhodopsin (
340TETSQVAPA) [20], and
therefore recognizes only the full length endogenous rhodopsin
(Fig. 3C). The weaker signal in the ONL seen in the 1D4 section
shows that some endogenous rhodopsin molecules were present in
this cellular compartment. However, the majority of the signal in
the outer nuclear layer in Fig. 3A appears to be due to Q344ter.
Together, the data presented so far indicate that Q344ter
mislocalization causes retinal degeneration in the mammalian
retina.
Q344ter can be co-transported on the post-Golgi vesicles to the
outer segment along with the full length endogenous rhodopsin
[12]. We bred Q344ter into the rho2/2 background to see
whether it may traffic alone to the outer segment, thereby
revealing an alternate trafficking motif. In the Q344ter
rho2/2
frozen retinal sections, rhodopsin immunofluorescence was seen in
the outer nuclear layer and inner segment (Fig. 3E). The outer
segment layer is not detectable either by rhodopsin immunoflu-
orescence or in the DIC image (Fig. 3, E&F). Similarly, light
micrographs of epoxy resin embedded sections failed to show outer
segment structures in Q344ter
rho2/2 retinas. Their morphology
was indistinguishable from their transgene-negative littermates at
p30 (Fig. 4, A&B) or p60 (Fig. 4, C&D). Interestingly, the degree of
retinal degeneration was similar at p30 and p60 in the presence or
absence of Q344ter, indicating that Q344ter mis-trafficking does
not accelerate the rate of retinal degeneration in the rhodopsin
knockout (rho2/2) background. Quantitative measurements of
outer nuclear layer thickness of retinas from dark-reared
Figure 1. Generation of Q344ter transgenic mice. (A) Construct used to generate the Q344ter transgenic mice. In an 11-kb BamHI-flanked
genomic clone containing the murine rod opsin gene, codon Q344 was mutated to an early stop signal (bottom *). The resulting rhodopsin mutant is
missing the QVAPA domain but retains the six known potential phosphorylation sites (underlined). An AvrII site within the Q344ter transgene was
generated by two silent mutations. Capitalized nucleotides denote the introduced point mutations. (B) Scheme to establish transcript expression
level of the Q344ter transgene. The AvrII site is used to differentiate between Q344ter transgenic and WT transcript species. (C) Phosphor-image used
to establish transgene-to-total rhodopsin transcript ratio. Total rhodopsin transcripts from each murine retina were amplified by RT-PCR and divided
into two equal fractions. After AvrII digestion of one fraction, the enzyme-resistant 250 bp band is compared to the corresponding band from the
undigested fraction. (D) Detection of the Q344ter mutant by western blot. Equal fraction (1/800) of a retina was loaded onto each lane. R2-12N
monoclonal antibody recognizes the amino-terminus and identifies endogenous and Q344ter rhodopsin, while the 1D4 antibody recognizes only full
length endogenous rhodopsin. Q344ter expression in rho2/2 background was confirmed by R2-12N (left panel). As expected, these species were
not detected by 1D4 (right panel). Monomeric and dimeric rhodopsin migrate at 33 kD and 66 kD, respectively.
doi:10.1371/journal.pone.0010904.g001
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rho2/2 and their transgene-negative littermates at p30 are
shown in Fig. 5B, blue and black traces, respectively.
At the ultrastructural level, rods in the rho2/2 retinas do not
elaborate outer segments (Fig. 4E), consistent with previous reports
[18,22,23]. In these samples membranous stacked tubules of
,15 nm diameter were observed in cross sections and tangential
sections (Fig. 4E, inset). These may represent membrane cargoes
that failed to form discs in the absence of rhodopsin. Unexpect-
edly, outer segment structures were revealed under EM in the
retinas of Q344ter
rho2/2 mice at p30 (Fig. 4, F–H). In some
instances shortened and disorganized outer segment structures
(ros) can be seen distal to the connecting cilia (cc, Fig. 4, F&G). It is
not clear whether these disorganized structures result from a defect
in outer segment formation or stability. A similar morphologic
pattern was seen in the Q344ter
rho2/2 retinas at p60 (Fig. 4, I–K).
Inclusions of membranous whirls can be seen in some inner
segments (Fig. 4, I&J, arrowheads), and abundant membranous
debris is present in the subretinal space. Some of this debris are in
the form of discs, while others appear to be tubules similar to that
seen in the rho2/2 retinas (Fig. 4, J&K, m:arrows). At both ages
abundant 100–200 nm diameter vesicular structures were ob-
served in the interphotoreceptor space (Fig. 4, G–K, asterisks).
Thus, Q344ter is capable of forming outer segment structures,
although the morphology of these structures suggests that they are
not structurally stable.
Q344ter-initiated retinal degeneration is accelerated by
light-exposure
The heterogeneous disease progressions among ADRP patients
inheriting the same rhodopsin mutation indicate that environ-
mental conditions contribute to the severity of this disease. One
potential environmental candidate is light-exposure. By rearing
Q344ter mice and their negative littermate controls under
constant darkness versus light- exposure (3000 lux constant light-
exposure for 5 days), we could isolate the effect of rhodopsin mis-
trafficking alone as well as the combined effect of mis-trafficking
and light-exposure on retinal degeneration.
We measured the degree of degeneration by retinal morphom-
etry based on a previous method [24]. For statistical analysis
between sample populations, ONL thickness measurements were
recorded within a sub-region of the superior half and near the
optic nerve of each retina (Fig. 5A), which previously was
revealed to be the most sensitive region to light-damage [24,25].
Control pigmented mice of the C57/B6 genetic background with
undilated pupils do not undergo light-damage under our
experimental protocol [26]. In some experiments, we observed
a small effect of light-exposure in control rho+/2 retinas
(Fig. 5A). As mentioned previously, dark-reared Q344ter
rho+/2
retinas had thinner ONL than their non-transgenic littermates,
an effect attributable to rhodopsin mislocalization (Fig. 5A). This
degeneration is quite profoundly exacerbated by light-exposure
(Fig. 5A). In contrast, rho2/2 retinas did not exhibit light-
damage (Fig. 5B), consistent with a previous report that
rhodopsin is required for light-induced photoreceptor cell death
[27]. Interestingly, outer nuclear layer thicknesses were similar in
dark-reared Q344ter
rho2/2 mice and their trangene-negative
littermates (Fig. 5B, blue and black traces, respectively). Perhaps
the deleterious effect of rhodopsin mis-trafficking is offset by the
beneficial effect of rhodopsin expression in the rho2/2 retina.
This effect is maintained through p60 (Fig. 4). On the other hand,
light-exposure also exacerbated retinal degeneration in
Q344ter
rho2/2 mice (Fig. 5B), suggesting that mislocalized
Q344ter is activated by light-exposure.
Mislocalized rhodopsin is capable of light-activation
Exacerbation of retinal degeneration by light-exposure has been
observed for rhodopsin mutants that may or may not initiate a cell
death cascade that involves phototransduction. In a previous study
Figure 2. Q344ter transgene causes retinal degeneration independent of light. Images of retinal sections from epoxy-embedded eyecups
were taken just above the optic nerve region from Q344ter
rho+/2 (B, C) and their transgene-negative littermate control (A) mice at the indicated ages.
All mice were born and reared in the dark. (D) Rod outer segment structure from control transgene-negative rho+/2 mice. (E) Vesicular structures
(asterisks) within the interphotoreceptor space of Q344ter
rho+/2 retina. Arrow points to a degenerating structure. (F) Outer nuclear layer of
Q344ter
rho+/2 retina is devoid of vesicles. Scale bar in C (20 mm) is also representative for panels A and B. Scale bar =1 mm for D, E, and F. ros, rod
outer segment; RPE, retinal pigmented epithelium.
doi:10.1371/journal.pone.0010904.g002
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rhodopsin could be activated and leads to cell death [28]. Whether
mislocalized rhodopsin is capable of light-activation in vivo in the
vertebrate retina has not been addressed. Substantiating this
property may provide an important first step towards discovering
the mechanism(s) that leads to the observed light-accelerated
retinal degeneration in our transgenic Q344ter mouse model as
well as other Class I rhodopsin mutants.
We examined whether mislocalized rhodopsin is capable of
light-activation by assessing the light-dependent rhodopsin
phosphorylation by rhodopsin kinase [29,30]. Phosphorylated
rhodopsin species can be separated by isoelectric focusing (IEF),
blotted onto nitrocellulose, and visualized using antibodies
against rhodopsin. As shown in Fig. 5C, only non-phosphorylated
rhodopsin and opsin molecules were detected in retinas from
dark-reared mice. These non-phosphorylated species also existed
in light-exposed retinas, which indicate that not all rhodopsin
molecules in the retinas are phosphorylated under the described
light conditions. Upon light-exposure, six phosphorylated rho-
dopsin species that can be visualized with 4D2, an antibody
against rhodopsin’s N-terminus [31], appeared in the rho+/2
retinas (Fig. 5C, middle lanes). These species are also present in
Q344ter
rho+/2 retinas, but four additional bands are also present
in these samples (Fig. 5C left panel, 4D2, two lanes on the right).
To confirm that these four additional species originate from the
Q344ter population, we subsequently probed the same mem-
brane with 1D4 (Fig. 5C right panel, 1D4). We reasoned that if
the four additional rhodopsin species are phosphorylated
Q344ter molecules, then they would not be recognized by 1D4.
Indeed this was found to be the case: the bands recognized by
1D4 are the same between rho+/2 and Q344ter
rho+/2 samples,
corresponding only to full length endogenous rhodopsin.
Interestingly, 1D4 did not recognize the hexa-phosphorylated
rhodopsin species in both retinal types. Based on a previous study
that mapped the residues that contribute to 1D4 binding, it is
likely that phosphorylation at the T342 position abolished the
1D4 epitope [20].
Because Q344ter can be co-trafficked with full length rhodopsin
to the outer segment, the above experiment does not fully address
whether Q344ter located to the outer nuclear layer and inner
segment is capable of light-activation. To address this question
directly, phosphorylation of Q344ter was assessed in the rho2/2
background in which the majority of Q344ter is located in the
outer nuclear layer and inner segment compartments (Fig. 3E). As
can be seen in Fig. 5D, non-phosphorylated Q344ter
rho2/2 in the
dark-adapted sample is recognized by 4D2 but not 1D4.
Interestingly, 4D2 identified five phosphorylated Q344ter species
upon light-exposure as opposed to six in the rho+/2 control
sample. We speculate that the Q344ter truncation affected the
ability of rhodopsin kinase to phosphorylate Ser343, which is the
carboxyl-terminal residue in Q344ter. As expected, these phos-
phorylated Q344ter species are not recognized by 1D4. These
results indicate that mislocalized Q344ter is capable of
light-activation.
Figure 3. Q344ter rhodopsin is mislocalized and does not support ROS formation when expressed in the absence of endogenous
rhodopsin. Q344ter
rho+/2, Q344
rho2/2 mice and their transgene negative littermate were dark-reared and sacrificed at p28–31. Frozen retinal
sections immunostained with either the anti-N-terminal R2-12N (A, B, E), or the anti-C-terminal 1D4 (C, D) monoclonal antibodies against rhodopsin.
R2-12N immunostaining was restricted to the rod outer segment (ROS) in control rho+/2 sections (B), but extended to the rod inner segment (RIS)
and outer nuclear layer (ONL) in Q344ter
rho+/2 sections (A). 1D4 immunostaining revealed the presence of endogenous rhodopsin in the ONL in
Q344ter
rho+/2 retinas (C), which was not observed in retinas from negative transgene littermate controls (D). ROS structures were not detected in
Q344ter
rho2/2 retinal sections when stained with R2-12N (E) or imaged by DIC microscopy (F). Scale bars =20 mm.
doi:10.1371/journal.pone.0010904.g003
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in transgenic Q344ter mice
Since Q344ter is capable of activating transducin [12],
Q344ter
rho+/2 mice were bred into the Tra2/2 background to
see whether transducin signaling contributed to photoreceptor cell
death. Again, dark-reared Q344ter
rho+/2Tra2/2 mice had thinner
outer nuclear layer when compared to nontransgenic littermates
(rho+/2,T r a2/2), indicating that retinal degeneration induced
by mis-trafficking alone is not dependent on the presence of
transducin (Fig. 6A). Light-exposure caused a further thinning of
the outer nuclear layer although to a lesser degree when compared
to light-exposed Q344ter
rho+/2 mice that express transducin
(compare the cyan traces in Fig. 6A and Fig. 5A). These results
suggest that transducin signaling in the outer nuclear layer and
inner segment compartment contributed to photoreceptor cell
death. The lack of full rescue indicates that additional light-
induced pathways are involved.
Light-dependent formation of stable rhodopsin/arrestin (Arr1)
complex has been found to be toxic to Drosophila photoreceptors
[32,33]. We have also previously demonstrated that the K296E
opsin mutant caused retinal degeneration in the mammalian retina
through formation of K296E/Arr1 complex [34]. We hypothe-
sized that this effect is due to the mislocalized K296E forming a
complex with Arr1 in the outer nuclear layer and inner segment.
Figure 4. Q344ter transgene does not accelerate retinal degeneration in rho2/2 retinas. As in Figure 2, these images of retinal sections
from epoxy-embedded eyecups were taken just above the optic nerve region from Q344ter
rho2/2 (B, D) and their transgene-negative littermate
control (A, C) mice at p30 and p60. At both time points, ONL thicknesses appear similar in Q344ter
rho2/2 mice and their littermate controls (compare
A to B and C to D). Although progressive ONL thinning was observed in both groups, Q344ter does not appear to accelerate degeneration already
occurring in rho2/2 mice. Scale bar in D (20 mm) is representative for panels A–D. (E) Rho2/2 rod photoreceptors do not elaborate outer segment
structures. Instead, membrane tubules are seen (inset). The subretinal space is devoid of vesicular structures. Panels F–H are from p30 Q344ter
rho2/2
retinas, and I–K are from p60 Q344ter
rho2/2 retinas. (F) Short and disorganized rod outer segment can be seen distal to the connecting cilia. A
neighboring cone photoreceptor with a much more intact outer segment is shown for comparison. (G) The rod outer segments shown here are
thinner than normal (compare with Figure 2D). These structures are surrounded by apical processes from the RPE. (H) The membranous discs within
some outer segment structures appear to be unstable. Numerous vesicular structures are present in the extracellular space (asterisks). (I-K) Vesicular
structures are present in the interphotoreceptor space of Q344ter
rho2/2 retinas. Outer segments containing discs are evident, but they are
significantly compromised both in size and organization. Scale bars for E-K=1 mm. Panels I-K are taken at the same magnification. os, outer segment;
ros, rod outer segment; is, inner segment; cc, connecting cilium; RPE, retinal pigmented epithelium; m, membranous debris.
doi:10.1371/journal.pone.0010904.g004
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layer. (A) Q344ter
rho+/2 and nontransgenic littermate control mice or (B) Q344ter
rho2/2 and nontransgenic littermates control mice that were either
dark-reared only or exposed to continuous light (3000 lux with undilated pupils) for five days were sacrificed at p28–31. Retinal sections near the
optic nerve were analyzed by retinal morphometry. The diagram displays the mean (6 SD) ONL thickness along the entire span of the retina. We
focused on a light-sensitive region in the superior half near the optic nerve marked by a green asterisk where a slight ONL thinning occurred in light-
exposed nontransgenic mice when compared to their dark-reared counterparts. Under dark-rearing, Q344ter retinas showed a moderate level of
degeneration when compared to their transgene-negative littermate controls (p#0.05). Light-exposure induced a severe form of degeneration in
Q344ter transgenic retinas when compared to both light-exposed nontransgenic retinas and dark-reared Q344ter transgenic retinas (p#0.05). A
representative light microscopy image within this region from each group is displayed to the right. Scale bar =20 mm. (C) Isoelectric focusing gel of
retinal extract from designated mice was blotted onto nitrocellulose and probed with the indicated antibodies against rhodopsin. The numbers to
the right of each membrane image corresponds to the number of phosphates. In the left panel both Q344ter and WT rhodopsin molecules are
detected by the anti-N-terminal rhodopsin mAb 4D2. Only non-phosphorylated rhodopsin (0) and apo-opsin (0*) species were detected in retinas
from dark-reared mice. Light-exposure produced multiple phosphorylated rhodopsin species. Moreover, four extra bands (*) were detected in light-
exposed Q344ter
rho+/2 retinas. In the right panel, only WT rhodopsin molecules are detected by the anti-C-terminal rhodopsin mAb 1D4. Note that
the four extra bands in the light-exposed Q344ter
rho+/2 retinas detected by 4D2 are absent. (D) Mislocalized Q344ter molecules undergo light-
dependent phosphorylation. With the rho2/2 background, Q344ter molecules are mislocalized as shown by the absence of apparent ROS structures
with R2-12N immunostaining (Fig. 3E). Retinal homogenates from light-exposed Q344ter
rho2/2 mice were examined under similar IEF conditions
described in (B). Light-dependent phosphorylation patterns of Q344ter molecules were detected by 4D2 (left panel) but not by 1D4 (right panel). This
light-dependent phosphorylation pattern of Q344ter in these mice show that mislocalized Q344ter is capable of light-activation.
doi:10.1371/journal.pone.0010904.g005
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compartments, light-dependent formation of Q344ter/Arr1 com-
plex may be an underlying mechanism for light-induced cell death
in these mice. Although the genetic background (Q344ter
rho+/2,
Arr12/2,T r a2/2) would provide a more direct test for
potential toxicity arising from mislocalized rhodopsin/Arr1
complexes, we and others have observed evidence for an unknown
genetic factor that appears to make a subpopulation of Arr12/2,
Tra2/2 mice susceptible to severe light-induced degeneration
even at low light intensities [34,35], making this genetic
background unsuitable for the present study. To test the
hypothesis, we instead crossed the Q344ter
rho+/2 mice and their
negative littermate controls into the RK2/2,T r a2/2 genetic
background, which does not appear to exhibit low light-induced
retinal degeneration. Removing Tra was necessary when deleting
RK, since the absence of RK leads to prolonged activation of the
phototransduction cascade in the presence of dim light and will
induce retinal degeneration through a different mechanism
[35,36,37]. In the absence of RK there is no light-induced
rhodopsin phosphorylation, and without phosphorylation, arrest-
in’s affinity for light-activated rhodopsin is low [37,38,39,40], and
therefore little or no stable complex will be formed. If the
rhodopsin/Arr1 complex contributed to the severe retinal
degeneration in the light-exposed transgenic Q344ter
rho+/2
background (Fig. 5A), we would expect an amelioration of the
retinal morphology in the light-exposed transgenic retinas when
Q344ter is expressed in the RK2/2,T r a2/2 genetic back-
ground. As shown in Fig. 6B, dark-reared Q344ter mice also had
thinner ONL than their non-transgenic littermate controls in the
RK2/2,T r a2/2 background, indicating that mislocalization of
Q344ter alone is deleterious to rod photoreceptors in general. This
degeneration is again exacerbated by light-exposure. The degree
of degeneration is similar to that in the Tra2/2 background,
suggesting that the degree of rescue is contributed by removing
Figure 6. Light-exacerbated retinal degeneration in Q344ter mice is ameliorated in the Tra2/2 background. Dark-reared mice were
kept in darkness or exposed to light for 5 days as in Fig. 5 (A) Retinal morphometry of Q344ter
rho+/2 in the Tra2/2 background. In the dark-reared
group expression of the Q344ter transgene consistently caused a moderate thinning of the ONL. Light-exposure had no noticeable effect on the
transgene negative mice, but caused further thinning of the ONL in Q344ter
rho+/2 mice. However, this effect was less severe when compared to the
Tra+/+ background (Fig. 5A). (B) The Q344ter
rho+/2,T r a2/2 mice were further crossed into the RK2/2 background to prevent light-induced
formation of stable rhodopsin/Arr1 complexes. No additional rescuing effect beyond that seen in the Tra2/2 background was observed in the light-
exposed transgenic Q344ter mice in the RK2/2,T r a2/2 background. Representative light micrographs of retinal sections are shown on the right.
Scale bars =20 mm.
doi:10.1371/journal.pone.0010904.g006
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complex in the ONL and inner segment compartments.
Light-induced G-protein activation visualized by
[
35S]GTPcS autoradiography
Results from Figures 5 and 6 suggest that light-induced retinal
degeneration in Q344ter is in part mediated by transducin
signaling, and that additional pathway(s) are involved. As a starting
point of identifying such pathways, we investigated the participa-
tion of G-proteins inasmuch as rhodopsin is a G-protein coupled
receptor and is required for light-damage [27]. To visualize
activation of G-proteins in situ, frozen, unfixed retinal sections
from the indicated mice were incubated with [
35S]GTPcS
followed by autoradiography. In the darkness, the outer plexiform
layer is consistently labeled, reflecting the involvement of GTP
binding proteins in synaptic vesicle trafficking ([41], Fig. 7, A, D,
G). In control rho+/2 section, the outer segment layer became
strongly labeled upon light-exposure due to transducin activation
at this location (Fig. 7B). Notably, light also stimulated
[
35S]GTPcS labeling in the outer segment and inner segment
layers in the Tra-/2 retina, both in the littermate negative control
(Fig. 7, D&E) and in Q344ter positive retina (Fig. 7, G&H). The
specificity of the [
35S]GTPcS binding is demonstrated in Fig. 7 (C,
F, I) where an excess of cold GTPcS was included in the
incubation. Thus, rhodopsin activation catalyzed GTP loading in
protein(s) other than it’s known in vivo target, transducin. Such
novel signaling pathway(s) may contribute to light-induced retinal
degeneration in these mice.
Discussion
In this investigation we utilized transgenic Q344ter mice to gain
a better understanding of the pathways that contribute to retinal
degeneration in ADRP patients inheriting this rod opsin mutation.
It is known that the rhodopsin carboxyl-terminus contains a
sorting motif which associates with cytoplasmic proteins that assist
in its transport from the site of synthesis to the outer segment
[42,43]. In vitro evidence, transgenic mouse studies, as well as
occurrence of naturally occurring mutations in human populations
point to the carboxyl-terminal VxPx motif for interaction with
other transport proteins [10,21,44]. Consistent with this idea,
Q344ter, lacking this motif, exhibit a trafficking defect: immuno-
staining of Q344ter
rho+/2 retinal sections with the R2-12N
antibody revealed that rhodopsin localized not only to the rod
outer segment but also abnormally accumulated in the inner
segment and outer nuclear compartments. We show that Q344ter
expressed at 24% of total rhodopsin caused a moderate rate of
retinal degeneration in dark-reared mice, an experimental
condition that isolated the effect of rhodopsin mislocalization
(Fig. 2). This finding is consistent with a previous study by Tam et
al. that expressed Q350ter (analogous to mammalian Q344ter) in
transgenic Xenopus laevis [45]. They found that mislocalized
rhodopsin does not require activation to cause retinal degenera-
tion. Interestingly, we observed in a previous study that the
rhodopsin mutant, S334ter, did not cause noticeable retinal
degeneration in dark-reared mice when it was expressed at 10% of
total rhodopsin [15]. Therefore, the photoreceptor cell appears to
tolerate some degree of rhodopsin mislocalization by low level
expression of these trafficking mutants.
Electron microscopy showed numerous of sub-micron sized
vesicles and other debris in the interphotoreceptor matrix of
Q344ter
rho+/2 retinas. The presence of these vesicles was also
noted in the P347S transgenic mice [21] as well as in the
S334ter
rho+/2 retinas (data not shown). Thus, accumulation of
extracellular vesicles appears to be a commonality for rhodopsin
with carboxyl-terminal mutations that affect the QVAPA domain.
Figure 7. Light-dependent GTPcS loading (20 min exposure) in transgenic Q344ter frozen retinal sections. [
35S]GTPcS binding in situ
was performed on unfixed frozen retinal sections from mice with the indicated genetic backgrounds. Basal [
35S]GTPcS loading in the dark labels the
synaptic layers (A, D, E), while light-exposure lead to additional labeling at the inner and outer segment compartments (B, E, H). Panels C, F, and I
show non-specific background labeling. Scale bar =20 mm. All panels are taken at same magnification.
doi:10.1371/journal.pone.0010904.g007
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mutant mice that include tulp1 [46,47], tubby [48] and pcd [49].
These gene products may participate in the same pathway that
regulates rhodopsin transport to outer segment and thus share the
same pathogenesis of disease.
Ultrastructural studies of Q344ter
rho2/2 retinas revealed, for
the first time, the presence of outer segment structures which were
not detectable under light microscopy. How did the Q344ter
molecules arrive at the outer segment? One possibility is the
presence of a weak trafficking motif aside from VxPx. Alterna-
tively, these structures may have formed from bulk flow of post-
Golgi vesicles that arrived at the apical regions of the rod cell.
Future experiments will be needed to address these possibilities.
Another novel observation from our EM study is that the outer
segment discs from Q344ter
rho2/2 rods appeared to be disorga-
nized (Fig. 4H). It is tempting to speculate that the QVAPA
domain may contribute to the retention of rhodopsin at the outer
segment and/or stability of the disc structures. Yet another
possibility is that, due to the trafficking defect, the Q344ter
molecules did not reach a critical density on the disc membranes to
support stable disc structures. This proposed model would be
largely consistent with a previous study on another truncated
rhodopsin, S334ter [50]. Lee and Flannery showed S334ter
molecules at the distal end of connecting cilium when expressed in
the absence of endogenous WT rhodopsin. They proposed this
localization to be the outcome from random events and not
directional movement of the truncated rhodopsin molecules.
Our current study also reveals that light-exposure exacerbated
Q344-induced retinal degeneration. This observation is correlated
with our novel finding that mislocalized Q344ter is capable of
light-activation. These findings allow us to formulate the
hypothesis that light-dependent catalytically active Q344ter would
become accessible to proteins not normally encountered by
rhodopsin and initiate a signaling pathway in the inner
segment/outer nuclear compartments that leads to accelerated
degeneration. Such examples could be the activation of transducin
or an unknown G-protein [28]. The amelioration of the light-
induced retinal degeneration in Q344ter
rho+/2,T r a2/2 mice
suggests that Q344ter-catalyzed transducin signaling in the
inappropriate cellular compartments of outer nuclear layer and
inner segment may play a role. Because the GAP complex that
deactivates transducin-GTP is localized predominantly in the
outer segment [51,52], activated transducin in the inner segment
and outer nuclear layer compartments may remain in the active
conformation for a prolonged period of time and cause cell death.
Although an improvement of light-induced retinal degeneration
was observed in the Tra2/2 background, the lack of complete
rescue indicate that additional pathways are also involved. We
investigated the participation of G-proteins because rhodopsin is a
GPCR and is required for light-damage [27]. Indeed, the data
from [
35S]GTPcS labeling showed light-dependent GTP loading
in the inner and outer segment compartments in Tra2/2 retinas.
It is known that rhodopsin activates Gi and Go efficiently in vitro
[53,54]. Notably, Gi2 is expressed in the photoreceptors [55].
Therefore, it may be a target for rhodopsin activation in vivo.
Alternately, rhodopsin activation may indirectly lead to activation
of small G-proteins. Additional experiments are required to
identify these signaling pathways and their effect in the
photoreceptor cell.
We tested the hypothesis that light-activation of Q344ter in the
inner segment may have lead to formation of toxic rhodopsin/
arrestin complex that signaled cell death. However, a lack of
additional rescue in the Q344ter
rho+/2,T r a2/2,R K 2/2 mice
indicate that this pathway is likely not involved in this mouse
model. Such a difference between Q344ter and K296E mutations
may lie in the degree of phosphorylation and the stability of the
rhodopsin/Arr1 complex: K296E cannot bind 11-cis retinal and
exists in an active conformation as it is synthesized [56]. We found
it to be hightly phosphorylated and formed a stable complex with
Arr1 [34]. Q344ter, on the other hand, becomes phosphorylated
upon light-exposure and is only capable of five phosphorylations
(Fig. 5B). Unlike K296E, it undergoes MII decay. For these
reasons Q344ter may not form a stable complex with Arr1. In
summary, these results underscore the complex nature of retinal
degeneration induced by rhodopsin mutations.
It was observed that retinal degeneration in P347S transgenic
mice is accelerated in the absence of Tra [57]. In that study the
mice were raised under cyclic light, making a direct comparison to
our study difficult. We observed that Tra had little or no effect on
the degree of retinal degeneration in dark-reared Q344ter mice,
whereas the absence of Trawas protective on light-exposed
Q344ter mice (Figures 5A and 6). This discrepancy may be due
to differences in experimental protocols (cyclic light-reared for
P347S vs. dark-reared for Q344ter) or the nature of the rhodopsin
mutation itself. In the P347S mice lipofuscin fluorophores were
found to be elevated, perhaps due to a faster decay of MII to apo-
opsin and free all-trans-retinaldehyde [57]. We did not observe an
accumulation of lipofucsin in the Q344ter mice.
Light-exposure has been reported to accelerate retinal degen-
eration in animal models expressing P23H [25,58,59,60,61]. In
these situations, P23H most likely perturbs processes in rod cells
without itself becoming photolyzed since P23H is mis-folded. In
this case light-exposure likely compounded the deleterious effect of
P23H through a different pathway. Interestingly, studies have
shown that patients inheriting Class I rhodopsin mutants, i.e.
Q344ter, tend to have more severe cases of ADRP than patients
inheriting Class II rhodopsin mutants, i.e. P23H [62,63]. Because
patients are never restricted to dark-only conditions, the above
observation may be attributed to the activation of an unknown yet
deleterious rhodopsin signaling pathway(s) specific to the mis-
localized Class I rhodopsin mutants. This hypothesis is rendered
plausible with our observation that mis-trafficked Q344ter
molecules are capable of light-excitation.
Materials and Methods
Ethics Statement
All experimental procedures were performed in accordance
with the regulations established by the National Institute of Health
as well as with the Association for Research in Vision and
Ophthalmology. The experiments involving vertebrate animals
have been approved by the University of Southern California
Institutional Animal Care and Use Committee (IACUC, Protocol
#10275).
Generation of transgenic Q344ter mice and genotype
analysis by PCR and Southern blotting
The Q344ter rod opsin mutation, along with two silent
mutations which generated an AvrII restriction site designed for
genotyping purposes, was introduced into an 11 kb BamHI-
flanked genomic clone of the murine opsin gene [16]. The
construct was purified by the CsCl2 gradient method, and the
mutated rod opsin gene was released from its vector by BamHI
digestion. The digested DNA fragments were separated in a 0.8%
agarose gel, and the BamHI-flanked Q344ter gene fragment was
gel-extracted by using the QIAEXII kit (Qiagen, Valencia, CA).
After further purification with an Elutip-D column (Whatman
Schleicher & Schuell, Sanford, ME), this DNA fragment was
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generate transgenic Q344ter mice (Norris Transgenic Core
facility, Keck School of Medicine of USC, Los Angeles, CA). All
transgenic Q344ter mice and their negative littermate controls
were dark-reared (except when noted) to prevent potential
undesired light-dependent retinal degeneration [60,64,65,66],
and to isolate the effect of Q344ter mis-trafficking to photorecep-
tor cell death.
For genotyping, mouse-tail biopsy samples were used to extract
genomic DNA, from which a 376 bp PCR product was generated
by using the primer pair FACmRho6020 (59TCCGGAACTG-
TATGCTCACCAC39) and Rho3 (59TGAGGGAGGGGTACA-
GATCC39). This amplified product then was digested by AvrII. If
the mouse possessed the Q344ter transgene, two fragments (92 bp
and 284 bp) would result.
Q344ter transgenic mice were bred to rho2/2 mice [18] to
generate transgenic mice with the endogenous rhodopsin +/2 and
2/2 genetic background (rho+/2 and rho2/2, respectively).
PCR was performed to detect the presence of the rod opsin null
allele by using primers Rh1.1 (59 GTGCCTGGAGT-
TGCGCTGTGGG39 ) and Neo3 (59 CGGTGGATGTG-
GAATGTGTGCGAG 39). To distinguish between hemizygous
(+/2) and homozygous (2/2) rhodopsin knockout mice, we
performed Southern blot analysis based on a previous protocol
[67].
Determination of transgene expression level by RT-PCR
Q344ter transgene expression level was determined by quan-
tifying the mutant-to-total transcript ratio in transgenic Q344ter-
rho+/2 mice at postnatal days 30 (p30). As controls, this assay
included mice with the following genetic backgrounds: rho+/2;
Q344ter
rho2/2; and rho2/2. From the various dark-reared mice,
total RNA was isolated from individual retinas using the Trizol
Reagent (Invitrogen Corp., Carlsbad, CA), and reverse transcrip-
tion with random primers was performed to obtain cDNA. These
cDNA products served as templates, in which a 250 bp fragment
common to both WT and transgenic rod opsin transcript species -
beginning at the 39 of exon 4 and ending within exon 5 beyond the
sites of mutagenesis – was amplified by PCR with the primers
FACRhoEx4A (59 GGTCATCTACATCATGTTGAACAAGC
39) and mRh5 (59 TGAGGGAGCCTGCATGACCTCATCC
39). To label the amplification product, 10 mCi of a-
32P dCTP
(3000 Ci/mmol (GE Healthcare, Piscataway, NJ)) were added to
the PCR buffer. These amplified products were precipitated,
washed, resuspended in dH2O, and divided into two equal
aliquots. One aliquot of 7.0 ml was digested with AvrII for
Q344ter, and the other aliquot of equivalent volume was mock
digested. AvrII digestion of transgene transcripts results in two
fragments –122 bp and 128 bp. Both aliquots were then loaded in
a 3% 3:1 Nusieve agarose gel (ISC BioExpress, Kaysville, UT).
The PCR fragments were transferred to Zetaprobe blotting
membrane through capillary action with 0.4 N NaOH, and the
intensities of the 250 bp radioactive bands were analyzed using the
Storm 860 Phosphor Imager software (GE Healthcare). The
Q344ter transgene expression level was determined as: 1–
(intensity of AvrII-resistant radioactive PCR product in the
digested aliquot divided by the intensity of the total intact
radioactive PCR product in the undigested aliquot).
Western blot analysis
Retinas were dissected from dark-reared mice at p30 under
infrared illumination. Individual retinas were homogenized in
buffer [80 mM Tris-HCl pH 8.0; 4 mM MgCl2; protease
inhibitor cocktail (Roche Diagnostics, Indianapolis, IN); and
0.5 mM phenylmethylsulfonyl fluoride (PMSF)], and subsequently
incubated with DNase I (Roche Diagnostics) for 30–45 min at
room temperature. Equal volume of protein sample loading buffer
(100 mM Tris, pH 6.8, 0.2 M dithiothreitol (DTT), 8% SDS,
20% glycerol, dash of bromophenol blue) was added, and the
equivalent amounts of retina per sample (1/800) were loaded and
separated in a 12% Tris-glycine polyacrylamide gel (Invitrogen
Corp.). The protein samples then were transferred onto nitrocel-
lulose membrane (Whatman Schleicher & Schuell) and were
incubated with either the anti-N-terminal rhodopsin monoclonal
antibody, R2-12N (1:10,000) that recognizes residues 2–12 [19];
or the anti-C-terminal rhodopsin monoclonal antibody, 1D4
(1:20,000) that recognizes residues 340–348 [20]. Goat anti-mouse
IgG conjugated horseradish peroxidase (HRP; 1:10,000; Vector
Laboratories, Burlingame, CA) was used as the secondary
antibody, and the signal was detected using the ECL system (GE
Healthcare).
Rhodopsin immunofluorescence
All mice were dark-reared and sacrificed at p30. Before
enucleation, the superior pole for each mouse eye was cauterized
for orientation. The mouse eye was first placed in fixative solution
(4.0% paraformaldehyde, 0.5% glutaraldehyde in 0.1 M cacodyl-
ate buffer pH 7.2) for 5 min at room temperature (RT), after
which the cornea was removed, and the lens was removed 10 min
later. The eyecup was further fixed for 2 h and rinsed free of
fixative with 0.1 M cacodylate buffer pH 7.2. The tissues were
then infiltrated with 30% sucrose in 0.1 M cacodylate buffer for
14–18 hrs at 4uC, after which the eyecups were hemisected,
embedded in Tissue TekH O.C.T. (Sakura Kinetek U.S.A. Inc.,
Torrance, CA), and quickly frozen in liquid nitrogen. Ten micron
frozen sections were obtained with a Jung CM 3000 cryostat
machine (Leica Inc., Deerfield, IL). The retinal sections were
incubated for 1 hour in blocking solution [2.0% BSA, 0.3% Triton
X-100, and 2% goat serum in phosphate buffer saline (PBS)]. This
blocking solution also served as the dilution solution for all
involved antibodies. These sections were incubated with one of the
following mAbs: R2-12N (1:100) or 1D4 (1:1000). After washing
with blocking solution, the sections were incubated with a 1:100
dilution of FITC-conjugated rabbit anti-mouse IgG (Vector
Laboratories, Inc., Burlingame, CA). After a series of washing
and a short fix (5 min in 4.0% paraformaldehyde in PBS), the
sections were mounted with Vectashield (Vector Laboratories,
Inc.), cover-slipped, and analyzed with an AxioPlan 2 imaging
microscope (Carl Zeiss, Inc., Goettingen, Germany).
Light and electron microscopy and retinal morphometry
The Q344termice and their negative control littermates were
either dark-reared or dark-reared and exposed to five days of
continuous light (3000 lux with undilated pupils) preceding their
sacrifice. Eyecups were fixed and embedded in an epoxy resin as
previously described [15], and sectioned at 1 mmo r6 0 n m
thickness using an ultramicrotome (Leica Ultracut UCT, Leica
Microsystems, Bannockburn, USA) for LM and EM, respectively.
Electron micrographs were obtained on a JEOL JEM 2100
microscope. For retinal morphometry the eyecups were sectioned
at or near the vertical meridian as determined by the optic nerve,
and the outer nuclear layer thickness was measured based on a
previously described method [24]. Briefly, retinal section was
viewed by a microscope (406 objective) attached with a camera
lucida; and measurements were taken with the aid of a graphics
tablet (WACOM, Vancouver, WA) and the Axiovision LE Rel.
4.1. imaging software (Carl Zeiss Inc.). A stage micrometer
(Klarmann Rulings, Litchfield, NH) was used for calibration. Each
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equal segments from the optic nerve to either the superior or
inferior tip, and three measurements were taken and averaged for
each segment. Due to the thinness of the outer nuclear layer at the
optic nerve location, determination of the ten equal segments for
each hemisphere excluded the first 100 mm from the optic nerve
site. Statistically, when comparing sample populations to deter-
mine significant differences, t-tests were used with a=0.05.
Rhodopsin phosphorylation visualized by isoelectric
focusing (IEF)
Dark-reared p30 Q344ter mice in rho+/2 or rho2/2
background and their respective transgene-negative littermates
were either subjected to light-exposure by dilating their pupils and
exposed to 3000 lux for 0.5 hr or kept in the dark. Retinas were
collected and snap frozen in liquid nitrogen. Afterwards, all steps
were performed under infrared illumination until the end of
focusing run. The retinal samples were homogenized with a PT
1200 C polytron (Kinematica, Switzerland) in 400 ml homogeni-
zation buffer [25 mM Hepes pH 7.5, 100 mM EDTA, 50 mM
NaF, 5 mM adenosine, 1 mM PMSF, and protease inhibitors
(Roche Diagnostics)] and centrifuged at 19,0006g( 4 uC, 17 min).
After washing with 10 mM Hepes pH 7.5, the pellet was
resuspended in 1 ml regeneration buffer (10 mM Hepes pH 7.5,
0.1 mM EDTA, 50 mM NaF, 5 mM adenosine, 1 mM PMSF,
1 mM MgCl2, 2% BSA, protease inhibitors, and approx. 1000
pmol 11-cis retinal) and incubated overnight (O/N) at 4uC. The
samples were spun down at 19,0006g and washed with 10 mM
Hepes pH 7.5. The pellets were incubated in 50 ml or 100 ml
solubilization buffer [20 mM Hepes pH 7.5, 0.1 mM EDTA,
50 mM NaF, 5 mM adenosine, 1 mM PMSF, 1 mM MgCl2,
10 mM NaCl, 1% dodecyl-maltoside, 1 mM dithiothreitol,
protease inhibitors] for 3–24 hrs at 4uC. Glycerol was added to
the solubilized pellet samples, which were loaded onto an
acrylamide gel [5% acrylamide, 0.01% DM, 13.33% glycerol,
3.8% Pharmalyte pH 2.5–5 (GE Healthcare), 2.53% Pharmalyte
pH 5–8 (GE Healthcare), catalyzed by ammonium persulfate and
TEMED]. The sample amounts (fraction of a retina) are as
follows: rho+/2 (1/20); Q344ter
rho+/2 (1/10); rho2/2 and
Q344ter
rho2/2 (1/5). The samples were run at a constant 23 W,
with 0.04 M glutamic acid as the anode solution and 1.0 M
NaOH as the cathode solution, on a Pharmacia Flat Bed
Apparatus FBE300 (GE Healthcare) at 10uC for 2 h. Afterwards,
the proteins were transferred onto nitrocellulose membrane by
capillary action with PBS. The membranes were subjected to
immunoblotting analysis with 1D4 and R2-12N or 4D2
monoclonal antibodies.
[




rho+/2Tra2/2 and their transgene-
negative littermate controls were dark-reared and sacrificed at
P28–31. Unless otherwise stated, all work, including cryosection-
ing, was performed under infrared light. After removing the
cornea and lens, the eyecup was embedded in 3% low-melting
agarose (Sigma-Aldrich, St. Louis, MO) dissolved in Ames’s like
solution [10 mM HEPES pH 7.4, 2 mM NaHCO3, 110 mM
NaCl, 2.5 mM KCl, 1.0 ml CaCl2, 1.6 mM MgCl2,1 0 m M
glucose). The agarose-embedded eyecups were placed in Tissue
TekH O.C.T. compound (Sakura Kinetek U.S.A. Inc., Torrance,
CA) and frozen in liquid nitrogen. The frozen tissue were
transferred to 220uC and sectioned (10 mm) with a Jung CM 3000
cryostat machine (Leica Inc., Deerfield, IL).
The [
35S]GTPcS autoradiography was based on previously
described protocols with modifications [68,69]. After allowing the
frozen sections to reach room temperature, they were incubated
for 10 min in ROS buffer (20 mM HEPES pH 7.4, 120 mM KCl,
5 mM MgCl2, 1 mM dithiothreitol, 100 mM phenylmethylsulfonyl
fluoride) to remove the surrounding mounting medium. The tissue
samples were then equilibrated for 1 hour in preincubation buffer
[100 mm guanosine –59-O- diphosphate (GDP, disodium salt
form, MP Biomedicals, Irvine, CA), 2 mM b-nicotinamide
adenine dinucleotide phosphate (NADPH, reduced tetra(cyclo-
hexylammonium) salt form, Sigma-Aldrich) in ROS buffer]. The
tissue sections were then incubated with the ‘‘hot’’ reaction buffer
[100 nM GTPcS (Roche Diagnostics, Indianapolis, IN), 20 nM
[
35S]GTPcS (1000 Ci/mmol; GE Healthcare, Piscataway, NJ) in
preincubation buffer] and either remained in darkness or exposed
to light (3000 lux) for 20 min. Non-specific binding is measured
with ‘‘cold-excess’’ reaction buffer (20 mM GTPcS, 20 nM
[
35S]GTPcS in preincubation buffer) for 20 min. After incubation,
all tissue samples were transferred back to the dark and washed
465 min with ROS buffer and 1630 sec with dH2O. The sections
were then air dried for 20 min and submerged in autoradiography
emulsion NTB (Eastman Kodak Co., Rochester, NY), and allowed
to dry (30 min). Afterwards, the sample slides were stored in a
light-tight container at 280uC for 3 days.
To develop the film, the sample slides were submerged for
3.5 min in Developer-19 solution (Eastman Kodak Co.), rinsed
with dH2O, and submerged for 5 min in Kodak fixer solution.
After drying the slides for 20 minutes, the samples were stained
with 0.4% Toluidine Blue O solution (Sigma-Aldrich) and washed
with phosphate buffer saline (PBS). This staining of nuclei
provided general orientation of the retinal cell layers. The sections
were dehydrated in graded alcohol: 1610 min with 50%, 70%,
90% ethanol, 2610 min with 100% ethanol, and finally
2610 min xylene. The sections were viewed and photographed
with an AxioPlan 2 imaging system (Carl Zeiss, Inc.).
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